Summarize the major changes between the current standard and the final revision to Chapter <797> Pharmaceutical Compounding-Sterile Preparations.
Explain how and when to apply the standards in Chapter <797> when preparing compounded sterile products used in home infusion and other alternate infusion settings.
Discuss the implementation timeframe and method of enforcement for USP general chapters <797> and <800>.